James Priour - Net Worth and Insider Trading
James Priour Net Worth
The estimated net worth of James Priour is at least $33,310 dollars as of 2024-11-10. James Priour is the Chief Commercial Officer of Zymeworks Inc and owns about 2,003 shares of Zymeworks Inc (ZYME) stock worth over $33,310. Details can be seen in James Priour's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Priour has not made any transactions after 2021-04-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Priour
James Priour Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Priour owns 1 companies in total, including Zymeworks Inc (ZYME) .
Click here to see the complete history of James Priour’s form 4 insider trades.
Insider Ownership Summary of James Priour
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYME | Zymeworks Inc | 2021-04-13 | Chief Commercial Officer |
James Priour Latest Holdings Summary
James Priour currently owns a total of 1 stock. James Priour owns 2,003 shares of Zymeworks Inc (ZYME) as of April 13, 2021, with a value of $33,310.
Latest Holdings of James Priour
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZYME | Zymeworks Inc | 2021-04-13 | 2,003 | 16.63 | 33,310 |
Holding Weightings of James Priour
James Priour Form 4 Trading Tracker
According to the SEC Form 4 filings, James Priour has made a total of 1 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zymeworks Inc is the sale of 950 shares on April 13, 2021, which brought James Priour around $26,534.
Insider Trading History of James Priour
- 1
James Priour Trading Performance
James Priour Ownership Network
Ownership Network List of James Priour
Ownership Network Relation of James Priour
James Priour Owned Company Details
What does Zymeworks Inc do?
Who are the key executives at Zymeworks Inc?
James Priour is the Chief Commercial Officer of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .
Zymeworks Inc (ZYME) Insider Trades Summary
Over the past 18 months, James Priour made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .
In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.
Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zymeworks Inc Insider Transactions
James Priour Mailing Address
Above is the net worth, insider trading, and ownership report for James Priour. You might contact James Priour via mailing address: 1385 West 8th Avenue, Suite 540, Vancouver A1 V6h 3v9.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
